According to the latest report by IMARC Group, titled “Biomarker Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, offers a comprehensive analysis of the industry, which comprises insights on biomarker technologies market report. The report also includes competitor and regional analysis, and contemporary advancements in the global market.
The global biomarker technologies market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 13% during 2021-2026. Biomarker technologies represent the cost-effective and reliable detection tools that rely on various genetic biomarkers, such as ribonucleic acid (RNA) and deoxyribonucleic acid (DNA), for detecting pathogens. They are utilized in the drug discovery and development processes. Some of the commonly available biomarker technologies include next-generation sequencing (NGS), polymerase chain reaction (PCR), immunoassay, etc. As such, these technologies also find wide-ranging applications in the early diagnosis of cardiovascular diseases, nervous system disorders, infections, immunological and genetic disorders, cancer, etc.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Sample Report: https://www.imarcgroup.com/biomarker-technologies-market/requestsample
Biomarker Technologies Market Trends:
The inflating healthcare infrastructures across the globe are primarily driving the biomarker technologies market. Moreover, the expanding geriatric population, who are more susceptible to neurological and autoimmune diseases, is propelling the need for early and effective diagnosis, which, in turn, is further stimulating the market growth. Besides this, numerous advancements in biomarker technologies to provide accurate patient stratification and enable faster evaluation of structural changes in the brain are acting as significant growth-inducing factors. Additionally, the growing integration of digital biomarkers with artificial intelligence (AI), machine learning (ML), Internet of Things (IoT), etc., for collecting quantifiable, objective, physiological, and behavioral data is also bolstering the global market. Apart from this, the increasing investments in R&D activities by government bodies across countries to develop new drugs and therapeutic strategies are anticipated to fuel the biomarker technologies market over the forecasted period.
Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/biomarker-technologies-market
Key Market Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- Hoffmann-La Roche AG
- Illumina Inc.
- LI-COR Inc.
- Merck KGaA
- PerkinElmer Inc.
- QIAGEN N.V.
- Shimadzu Corporation
- Thermo Fisher Scientific Inc.
- Waters Corporation
Breakup by Test Type:
- Solid Biopsy
- Liquid Biopsy
Breakup by Indication:
- Cancer
- Infectious Diseases
- Autoimmune Disorders
- Cardiovascular Disorders
- Others
Breakup by Product:
- Consumables
- Assay
- Reagent
- Instruments
Breakup by Technology:
- Polymerase Chain Reaction (PCR)
- Next Generation Sequencing (NGS)
- Immunoassay
- Others
Breakup by Application:
- Drug Discovery
- Clinical Diagnostics
- Personalized Medicine
Breakup by Region:
- Middle East and Africa
- North America
- Asia-Pacific
- Europe
- Latin America
Key highlights of the Report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
